PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
94 hedge funds and large institutions have $78.4M invested in Poseida Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $136M → $78.4M (-$57.6M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
94
Holding in Top 10
–
Calls
$195K
Puts
$40K
Top Buyers
| 1 | +$5.8M | |
| 2 | +$1.56M | |
| 3 | +$1.26M | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$941K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$715K |
Top Sellers
| 1 | -$3.47M | |
| 2 | -$3.3M | |
| 3 | -$3.08M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.68M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.15M |